Location History:
- Dublin, OH (US) (2009)
- Bronx, NY (US) (2011)
Company Filing History:
Years Active: 2009-2011
Title: The Innovations of Ross Bland
Introduction
Ross Bland is an accomplished inventor based in the Bronx, NY. He has made significant contributions to the field of neurobiology through his innovative work. With a total of two patents to his name, Bland is recognized for his advancements in treating neurodegenerative diseases.
Latest Patents
Bland's latest patents include the Glutamic Acid Decarboxylase (GAD) chimera and methods of use. This invention relates to a novel Glutamic Acid Decarboxylase (GAD), specifically focusing on novel DNA and protein sequences associated with GAD. The invention also discloses a novel composition and related methods for treating neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and epilepsy. It utilizes both viral and non-viral delivery systems to target specific regions of the brain. Notably, an adeno-associated viral vector is employed to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to areas of the brain that are overstimulated or disinhibited in various diseases.
Career Highlights
Bland is currently associated with Neurologix, Inc., where he continues to develop innovative solutions for neurological disorders. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from debilitating conditions.
Collaborations
Bland collaborates with Helen Fitzsimons, contributing to the advancement of research in neurobiology and therapeutic methods.
Conclusion
Ross Bland's contributions to the field of neurobiology through his patents and work at Neurologix, Inc. highlight his commitment to innovation in treating neurodegenerative diseases. His inventions have the potential to significantly impact the lives of many individuals affected by these conditions.